{"id":"https://openalex.org/W3210463590","doi":"https://doi.org/10.3389/fimmu.2021.765747","title":"How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?","display_name":"How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?","alternate_titles":[],"publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3210463590","doi":"https://doi.org/10.3389/fimmu.2021.765747","mag":"3210463590","pmid":"https://pubmed.ncbi.nlm.nih.gov/34790200","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8591239"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2021.765747","doi":"https://doi.org/10.3389/fimmu.2021.765747","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.765747","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.765747/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3210463590"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.765747/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004318668","display_name":"Alessandra Vultaggio","orcid":"https://orcid.org/0000-0002-8775-9217","observed_orcids":["https://orcid.org/0000-0002-8775-9217"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alessandra Vultaggio","raw_affiliation_strings":["Immunoallergology Unit, Careggi University Hospital, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunoallergology Unit, Careggi University Hospital, Florence, Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053085869","display_name":"Margherita Perlato","orcid":"https://orcid.org/0000-0003-1877-4517","observed_orcids":["https://orcid.org/0000-0003-1877-4517"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Margherita Perlato","raw_affiliation_strings":["Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy","institution_ids":["https://openalex.org/I45084792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019333295","display_name":"Francesca Nencini","orcid":"https://orcid.org/0000-0002-3868-8969","observed_orcids":["https://orcid.org/0000-0002-3868-8969"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Nencini","raw_affiliation_strings":["Immunoallergology Unit, Careggi University Hospital, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunoallergology Unit, Careggi University Hospital, Florence, Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072043071","display_name":"Emanuele Vivarelli","orcid":"https://orcid.org/0000-0001-5955-5076","observed_orcids":["https://orcid.org/0000-0001-5955-5076"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emanuele Vivarelli","raw_affiliation_strings":["Immunoallergology Unit, Careggi University Hospital, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunoallergology Unit, Careggi University Hospital, Florence, Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091577314","display_name":"Enrico Maggi","orcid":"https://orcid.org/0000-0002-1824-3583","observed_orcids":["https://orcid.org/0000-0002-1824-3583"]},"institutions":[{"id":"https://openalex.org/I4210123352","display_name":"Bambino Ges\u00f9 Children's Hospital","ror":"https://ror.org/02sy42d13","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210123352","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Enrico Maggi","raw_affiliation_strings":["Translational Immunology Unit, Immunology Area, Pediatric Hospital Bambino Ges\u00f9, Istituto di Ricovero e Cura a Carattere Scientifico (IRCSS), Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Immunology Unit, Immunology Area, Pediatric Hospital Bambino Ges\u00f9, Istituto di Ricovero e Cura a Carattere Scientifico (IRCSS), Rome, Italy","institution_ids":["https://openalex.org/I4210123352","https://openalex.org/I4210153126"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014039023","display_name":"Andrea Matucci","orcid":"https://orcid.org/0000-0002-8713-4161","observed_orcids":["https://orcid.org/0000-0002-8713-4161"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Matucci","raw_affiliation_strings":["Immunoallergology Unit, Careggi University Hospital, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunoallergology Unit, Careggi University Hospital, Florence, Italy","institution_ids":["https://openalex.org/I4210115393"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5004318668","https://openalex.org/A5091577314"],"corresponding_institution_ids":["https://openalex.org/I4210115393","https://openalex.org/I4210123352","https://openalex.org/I4210153126"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":0.7378,"has_fulltext":true,"cited_by_count":47,"citation_normalized_percentile":{"value":0.5554878,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"12","issue":null,"first_page":"765747","last_page":"765747"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9434000253677368,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9434000253677368,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.037300001829862595,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.8960000276565552},{"id":"https://openalex.org/keywords/hypersensitivity","display_name":"hypersensitivity","score":0.828000009059906},{"id":"https://openalex.org/keywords/biologicals","display_name":"biologicals","score":0.7940000295639038},{"id":"https://openalex.org/keywords/drug-desensitization","display_name":"drug desensitization","score":0.9620000123977661},{"id":"https://openalex.org/keywords/ige-mediated-hypersensitivity","display_name":"IgE-mediated hypersensitivity","score":0.9419999718666077},{"id":"https://openalex.org/keywords/non-ige-mediated-hypersensitivity","display_name":"non-IgE-mediated hypersensitivity","score":0.8140000104904175},{"id":"https://openalex.org/keywords/infusion-regimen","display_name":"infusion regimen","score":0.6320000290870667},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.8199999928474426},{"id":"https://openalex.org/keywords/mast-cell-degranulation","display_name":"mast cell degranulation","score":0.8460000157356262},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.7160000205039978},{"id":"https://openalex.org/keywords/rheumatic-diseases","display_name":"rheumatic diseases","score":0.6000000238418579},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8229966163635254},{"id":"https://openalex.org/C2779779143","wikidata":"https://www.wikidata.org/wiki/Q3493547","display_name":"Desensitization (medicine)","level":3,"score":0.793588399887085},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.6807041168212891},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6399692296981812},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5094502568244934},{"id":"https://openalex.org/C2778826181","wikidata":"https://www.wikidata.org/wiki/Q3310538","display_name":"Culprit","level":3,"score":0.49845457077026367},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4906686544418335},{"id":"https://openalex.org/C49802076","wikidata":"https://www.wikidata.org/wiki/Q5251810","display_name":"Degranulation","level":3,"score":0.44567161798477173},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4421417713165283},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.41130805015563965},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23506313562393188},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09236058592796326},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2021.765747","doi":"https://doi.org/10.3389/fimmu.2021.765747","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.765747","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.765747/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmid:34790200","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34790200","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8591239","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8591239/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:f6763b2ca24f4d82b0d401be2f79585f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f6763b2ca24f4d82b0d401be2f79585f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 12 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2021.765747","doi":"https://doi.org/10.3389/fimmu.2021.765747","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.765747","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.765747/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3210463590.pdf","grobid_xml":"https://content.openalex.org/works/W3210463590.grobid-xml"},"referenced_works_count":59,"referenced_works":["https://openalex.org/W46008683","https://openalex.org/W1966439074","https://openalex.org/W1981034102","https://openalex.org/W1983844355","https://openalex.org/W1991229597","https://openalex.org/W1991810959","https://openalex.org/W1997999969","https://openalex.org/W2000768707","https://openalex.org/W2002716405","https://openalex.org/W2018178851","https://openalex.org/W2018600081","https://openalex.org/W2020976460","https://openalex.org/W2026544302","https://openalex.org/W2035193481","https://openalex.org/W2040105226","https://openalex.org/W2041806010","https://openalex.org/W2069884383","https://openalex.org/W2073213739","https://openalex.org/W2088629488","https://openalex.org/W2090685459","https://openalex.org/W2094502152","https://openalex.org/W2108160031","https://openalex.org/W2117212747","https://openalex.org/W2129592053","https://openalex.org/W2133803808","https://openalex.org/W2135090710","https://openalex.org/W2140035322","https://openalex.org/W2141139109","https://openalex.org/W2142953742","https://openalex.org/W2159628003","https://openalex.org/W2402935502","https://openalex.org/W2414319593","https://openalex.org/W2486217873","https://openalex.org/W2521400558","https://openalex.org/W2523881981","https://openalex.org/W2541768017","https://openalex.org/W2549232442","https://openalex.org/W2565061901","https://openalex.org/W2566723850","https://openalex.org/W2590338062","https://openalex.org/W2611033082","https://openalex.org/W2747202372","https://openalex.org/W2797187980","https://openalex.org/W2798249501","https://openalex.org/W2886991706","https://openalex.org/W2996323809","https://openalex.org/W2999008604","https://openalex.org/W3062976875","https://openalex.org/W3093572871","https://openalex.org/W3095158811","https://openalex.org/W3114499220","https://openalex.org/W3121324814","https://openalex.org/W3158663883","https://openalex.org/W3170507761","https://openalex.org/W3176452932","https://openalex.org/W3181732986","https://openalex.org/W3184316169","https://openalex.org/W4229620302","https://openalex.org/W4406597345"],"related_works":["https://openalex.org/W2079404769","https://openalex.org/W2188359181","https://openalex.org/W3014965473","https://openalex.org/W2981547965","https://openalex.org/W3179826292","https://openalex.org/W2131930810","https://openalex.org/W1923220400","https://openalex.org/W2184862354","https://openalex.org/W4403660386","https://openalex.org/W2241931350"],"abstract_inverted_index":{"Biologicals":[0],"are":[1,16,55,128,151,214],"widely":[2],"used":[3],"therapeutic":[4],"agents":[5],"for":[6],"rheumatologic":[7],"diseases,":[8],"cancers,":[9],"and":[10,21,125,208],"other":[11],"chronic":[12],"inflammatory":[13],"diseases.":[14],"They":[15],"characterized":[17],"by":[18,68,76],"complex":[19],"structures":[20],"content":[22],"of":[23,26,44,64,105,115,136,204,219],"variable":[24],"amounts":[25],"foreign":[27],"regions,":[28],"which":[29],"may":[30,39,48,108,157],"lead":[31],"to":[32,89,101,110,120,132,143,165],"anti-drug":[33],"antibodies":[34],"(ADA)":[35],"development.":[36],"ADA":[37,117],"onset":[38],"limit":[40],"the":[41,103,113,134,145,185,196,202,217],"clinical":[42],"usage":[43],"biologicals":[45],"because":[46],"they":[47,54],"decrease":[49],"their":[50],"safety.":[51],"In":[52,139],"fact":[53],"mainly":[56],"associated":[57,200],"with":[58,167,201],"immediate":[59],"hypersensitivity":[60],"reactions":[61],"(HSRs).":[62],"Development":[63],"ADAs":[65,93,107,127],"is":[66,74,118,199],"reduced":[67],"concomitant":[69],"immunosuppressive":[70],"treatment,":[71],"while":[72],"it":[73,172],"increased":[75],"longer":[77],"intervals":[78],"between":[79],"drug":[80,154],"administrations;":[81],"thus,":[82],"regular":[83],"infusion":[84],"regimens":[85],"should":[86,161],"be":[87,99,121,158,162,174],"preferred":[88],"reduce":[90,102,133],"HSRs.":[91,106,183],"Once":[92],"have":[94],"formed,":[95],"some":[96,212],"procedures":[97],"can":[98,173],"implemented":[100],"risk":[104,135],"belong":[109],"different":[111],"isotype;":[112],"detection":[114],"IgE":[116],"advisable":[119],"assessed":[122],"when":[123],"high":[124],"early":[126],"detected,":[129],"in":[130,177],"order":[131],"severe":[137],"HRs.":[138],"patients":[140,166,178],"who":[141,179],"need":[142],"reintroduce":[144],"biological":[146],"culprit,":[147],"as":[148],"alternative":[149],"therapies":[150],"not":[152,192],"available,":[153],"desensitization":[155],"(DD)":[156],"applied.":[159],"Desensitization":[160],"conceptually":[163],"dedicated":[164],"an":[168],"IgE-mediated":[169],"HSR;":[170],"however,":[171],"performed":[175],"also":[176],"had":[180],"developed":[181],"non-IgE-mediated":[182],"Although":[184],"underlying":[186],"mechanisms":[187],"behind":[188],"successful":[189],"DD":[190,197],"has":[191],"been":[193],"fully":[194],"clarified,":[195],"procedure":[198],"inhibition":[203,218],"mast":[205],"cell":[206],"degranulation":[207],"cytokine":[209],"production.":[210],"Additionally,":[211],"data":[213],"emerging":[215],"about":[216],"drug-specific":[220],"immune":[221],"responses":[222],"during":[223],"DD.":[224]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3210463590","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":7}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2021-11-08T00:00:00"}
